Medifast, Inc.
MED
$13.80
-$0.02-0.15%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 130.42% | -109.28% | -86.73% | -95.13% | -126.93% |
| Total Depreciation and Amortization | 31.89% | 0.58% | 269.07% | -275.73% | -8.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.17% | 247.46% | -227.29% | 590.73% | 347.36% |
| Change in Net Operating Assets | -1,001.53% | 65.09% | 47.42% | -80.34% | -118.83% |
| Cash from Operations | -125.85% | -53.23% | -147.02% | -69.69% | -69.71% |
| Capital Expenditure | 28.90% | 17.33% | -141.54% | 17.16% | -11.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,580.64% | 43.04% | -75.23% | 99.12% | -- |
| Cash from Investing | 627.53% | 25.98% | -81.07% | 96.16% | -45.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | 93.75% | 54.83% | 90.00% | 98.18% | -700.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 75.00% | 72.68% | 100.00% | 99.99% | 99.98% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.00% | 62.24% | 99.99% | 99.98% | 99.89% |
| Foreign Exchange rate Adjustments | -- | -- | 100.00% | -84.62% | -68.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.39% | -73.97% | -33.14% | 121.04% | -55.43% |